Andrew Vorhees

Left Guard

Age: 24
Free Agency: 2027 (UFA)
Accrued Seasons: 0
  • 2023 Salary Cap Charge: $475,528 (0.21% of cap)
  • 2023 Cash Payout: $552,112 (0.20% of spending)
  • 2023 Cash to Cap Ratio: 1.16
  • Contract Value: $3,942,112 ($985,528 APY)
  • Fully Guaranteed Money: $102,112
  • Contract Ranking: 51/91 at LG

Current Contract

(Drafted, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusCap
Cap %
Dead Money & Cap Savings

Contract Notes

Andrew Vorhees signed a four year contract worth $3,942,112 with the Ravens on May 4, 2023. The contract has $102,112 in guarantees. He received a signing bonus worth $102,112.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
Old Money2023202420252026
Cash Due$300,000$552,112$915,000$1,030,000$1,145,000
Running Cash$852,112$1,767,112$2,797,112$3,942,112
Career Earnings: $102,112
Career APY: $0
Potential Earnings: $3,642,112
Total Guarantees: $102,112
Largest Cash Payment: $1,145,000 (2026)
Largest Cap Number: $1,170,528 (2026)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money


No statistics available.

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Injury Adjusted$0$0
OTC Valuation $2.1M $4.3M $6.4M $8.6M $10.7M APY $3.3M $6.7M $10M $13.3M $16.7M $4,906,000 $3,063,993

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.